- $15.57bn
- $14.42bn
- $2.82bn
- 100
- 35
- 97
- 92
Annual income statement for F5, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,351 | 2,603 | 2,696 | 2,813 | 2,816 |
| Cost of Revenue | |||||
| Gross Profit | 1,943 | 2,117 | 2,156 | 2,220 | 2,258 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,959 | 2,209 | 2,292 | 2,341 | 2,158 |
| Operating Profit | 392 | 394 | 404 | 473 | 659 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 396 | 387 | 385 | 486 | 695 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 307 | 331 | 322 | 395 | 567 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 307 | 331 | 322 | 395 | 567 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 307 | 331 | 322 | 395 | 567 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.42 | 6.03 | 5.47 | 7.43 | 9.67 |